Phase I Clinical Trial of YKYY031 for Injection in Patients With Advanced Solid Tumors

NCT07631793 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

76

Enrollment

INDUSTRY

Sponsor class

Conditions

Malignant Neoplasms

Interventions

DRUG: YKYY031 group (the first stage)
DRUG: YKYY031 group (the second stage)

Sponsor

Beijing Youcare Kechuang Pharmaceutical Technology Co., Ltd.